Every toxicologist, regardless of whether they are active in academia, industry, or the regulatory field, has had to deal with research results not being applicable to everyone. This can be due to a specific study design or exclusion of certain individuals from participating in research. Even in present day drug development, we see examples of widespread adverse effects after compounds have entered the market, because large groups of the population are being left out in (clinical) studies. Standard research, one size, does not fit all. But what should we do? How can we address this? And what can we do to be more inclusive?
This annual NVT meeting will highlight the progress made and challenges ahead spanning different fields of toxicology. We will focus on selecting the right study design and discuss how toxicology can be more inclusive. We will cover all sizes: from nanoparticles to biomaterials and from personalized medicine to population risk assessment.
Best regards,
NVT organizing committee